US74319F1075 - Common Stock
BIORA THERAPEUTICS INC
NASDAQ:PROG (5/6/2022, 7:00:02 PM)
After market: 0.9 +0.02 (+1.75%)0.8845
-0.03 (-3.47%)
Progenity, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. The company is headquartered in San Diego, California and currently employs 124 full-time employees. The company went IPO on 2020-06-19. The company delivers therapeutics in two areas: targeted delivery of therapeutics to the site of disease in the gastrointestinal tract and systemic delivery of biotherapeutics. Its research and development pipeline consists of Drug Delivery System (DDS), PGN-600, PGN-001, Oral Biotherapeutics Delivery System (OBDS), PGN-OB1 and PGN-OB2. PGN-600 is liquid formulation of tofacitinib delivered with the DDS for the treatment of ulcerative colitis. PGN-001 is an orally-delivered variant of adalimumab for the treatment of ulcerative colitis. PGN-OB1 is a combination product of a variant of adalimumab and the OBDS for the treatment of inflammatory conditions. PGN-OB2 is a combination product of a GLP-1 receptor agonist and the OBDS for the treatment of Type two diabetes. The OBDS platform is designed to enable delivery of liquid drug, reducing the need for reformulation.
BIORA THERAPEUTICS INC
4330 La Jolla Village Drive, Suite 200
San Diego CALIFORNIA 92122
P: 18552932639.0
CEO: Harry Stylli
Employees: 124
Website: https://www.progenity.com/
Biora's product is supposed to enable biologics to be delivered directly to GI tracts. BIOR stock is a favorite of retail investors.
Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy...
Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms...
Upcoming Change Reflects the Company’s Focus on Oral Delivery of Biotherapeutics...
SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for...
Here you can normally see the latest stock twits on PROG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: